HomeDNTH • NASDAQ
add
Dianthus Therapeutics Inc
Previous close
$80.32
Year range
$13.37 - $88.02
Market cap
3.57B USD
Avg Volume
1.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 284.00K | -78.58% |
Operating expense | 69.82M | 110.05% |
Net income | -64.43M | -126.55% |
Net profit margin | -22.69K | -957.78% |
Earnings per share | -1.43 | -104.31% |
EBITDA | -69.51M | -117.98% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 404.30M | 46.89% |
Total assets | 530.92M | 41.95% |
Total liabilities | 37.52M | 74.27% |
Total equity | 493.40M | — |
Shares outstanding | 44.47M | — |
Price to book | 7.03 | — |
Return on assets | -31.37% | — |
Return on capital | -33.35% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -64.43M | -126.55% |
Cash from operations | -46.98M | -71.20% |
Cash from investing | 37.20M | 260.98% |
Cash from financing | 4.88M | -87.69% |
Net change in cash | -4.90M | 54.98% |
Free cash flow | -24.73M | -97.11% |
About
Founded
2019
Website
Employees
92
